Moderna acquires OriCiro for $85 million
OriCiro Genomics is a Japanese bio-innovative therapeutics developer focused on cell-free synthesis and amplification of genomes for advanced therapeutics and synthetic biology. Recently, Moderna announced that it will spend $85 million to acquire OriCiro Genomics, headquartered in Tokyo, Japan. This article is transferred from: https://www.itjuzi.com/merger/9613 This site is only for collection, and the copyright belongs […]
Moderna acquires OriCiro for $85 million Read More »